Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H W Reesink

Showing results (41-50 of 250) with videos related to

Pageof 25
Sort By:
Vox Sanguinis|January 1, 1987
Preparation of leukocyte-poor platelet concentrates from buffy coats. I. Special inserts for centrifuge cupsR N Pietersz, H W Reesink, W J Dekker, et al.
Vox Sanguinis|January 1, 1994
Should the c100 antigen be removed from HCV antibody assays?H L Zaaijer, H T Cuypers, H W Reesink, et al.
Journal of Gastroenterology|November 1, 2001
Development of myasthenia gravis during treatment of chronic hepatitis C with interferon-alpha and ribavirinC J Weegink, R A Chamuleau, H W Reesink, et al.
Vox Sanguinis|December 3, 2009
New developments in antiviral therapy for chronic hepatitis BR B Takkenberg, C J Weegink, H L Zaaijer, et al.
Nederlands Tijdschrift Voor Geneeskunde|September 22, 1990
[The use of a mixture of citrated erythrocytes and heparin plasma for exchange transfusions]M A Brink, M J Derks, R N Pietersz, et al.
Nederlands Tijdschrift Voor Geneeskunde|December 14, 1991
[Are there still indications for plasma transfusions?]P C Huijgens, G J Ossenkoppele, R N Pietersz, et al.
Infusionstherapie (Basel, Switzerland)|June 1, 1991
Impact of leukocytes on the storage of platelet concentratesR N Pietersz, D de Korte, W J Dekker, et al.
Vox Sanguinis|April 28, 2009
New developments in the antiviral treatment of hepatitis CJ de Bruijne, C J Weegink, P L M Jansen, et al.
Vox Sanguinis|August 1, 1980
Comparison of sic 'Third-Generation' tests for the detection of HBsAgH W Reesink, L J Lafeber-Schut, C Aaij, et al.
Vox Sanguinis|January 1, 1988
Preparation of leucocyte-poor platelet concentrates from buffy coats. IV. Clinical evaluationR N Pietersz, H W Reesink, P C Huijgens, et al.
Pageof 25

Showing results (41-50 of 250) with videos related to

Sort By:
Pageof 25
Vox Sanguinis|January 1, 1987
Preparation of leukocyte-poor platelet concentrates from buffy coats. I. Special inserts for centrifuge cupsR N Pietersz, H W Reesink, W J Dekker, et al.
Vox Sanguinis|January 1, 1994
Should the c100 antigen be removed from HCV antibody assays?H L Zaaijer, H T Cuypers, H W Reesink, et al.
Journal of Gastroenterology|November 1, 2001
Development of myasthenia gravis during treatment of chronic hepatitis C with interferon-alpha and ribavirinC J Weegink, R A Chamuleau, H W Reesink, et al.
Vox Sanguinis|December 3, 2009
New developments in antiviral therapy for chronic hepatitis BR B Takkenberg, C J Weegink, H L Zaaijer, et al.
Nederlands Tijdschrift Voor Geneeskunde|September 22, 1990
[The use of a mixture of citrated erythrocytes and heparin plasma for exchange transfusions]M A Brink, M J Derks, R N Pietersz, et al.
Nederlands Tijdschrift Voor Geneeskunde|December 14, 1991
[Are there still indications for plasma transfusions?]P C Huijgens, G J Ossenkoppele, R N Pietersz, et al.
Infusionstherapie (Basel, Switzerland)|June 1, 1991
Impact of leukocytes on the storage of platelet concentratesR N Pietersz, D de Korte, W J Dekker, et al.
Vox Sanguinis|April 28, 2009
New developments in the antiviral treatment of hepatitis CJ de Bruijne, C J Weegink, P L M Jansen, et al.
Vox Sanguinis|August 1, 1980
Comparison of sic 'Third-Generation' tests for the detection of HBsAgH W Reesink, L J Lafeber-Schut, C Aaij, et al.
Vox Sanguinis|January 1, 1988
Preparation of leucocyte-poor platelet concentrates from buffy coats. IV. Clinical evaluationR N Pietersz, H W Reesink, P C Huijgens, et al.
Pageof 25